These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25035225)

  • 21. Dose and Volume of the Irradiated Main Bronchi and Related Side Effects in the Treatment of Central Lung Tumors With Stereotactic Radiotherapy.
    Duijm M; Schillemans W; Aerts JG; Heijmen B; Nuyttens JJ
    Semin Radiat Oncol; 2016 Apr; 26(2):140-8. PubMed ID: 27000511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vocal cord paralysis after stereotactic body radiation therapy to the left lung apex.
    Carpenter TJ; Rosenzweig KE
    J Thorac Oncol; 2014 Nov; 9(11):e80-1. PubMed ID: 25436809
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitative evaluation of correlation of dose and FDG-PET uptake value with clinical chest wall complications in patients with lung cancer treated with stereotactic body radiation therapy.
    Algan O; Confer M; Algan S; Matthiesen C; Herman T; Ahmad S; Ali I
    J Xray Sci Technol; 2015; 23(6):727-36. PubMed ID: 26756408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity.
    Murray L; Karakaya E; Hinsley S; Naisbitt M; Lilley J; Snee M; Clarke K; Musunuru HB; Ramasamy S; Turner R; Franks K
    Br J Radiol; 2016; 89(1058):20150628. PubMed ID: 26760508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchiolitis obliterans organizing pneumonia after stereotactic ablative radiation therapy for lung cancer: A case report.
    Fanetti G; Bazzani F; Ferrari A; Alterio D; Donghi SM; Pounou Kamga FA; Orecchia R; Jereczek-Fossa BA
    Cancer Radiother; 2018 Feb; 22(1):57-61. PubMed ID: 29395853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).
    Dunlap NE; Larner JM; Read PW; Kozower BD; Lau CL; Sheng K; Jones DR
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):583-9. PubMed ID: 20478576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver.
    Andolino DL; Forquer JA; Henderson MA; Barriger RB; Shapiro RH; Brabham JG; Johnstone PA; Cardenes HR; Fakiris AJ
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):692-7. PubMed ID: 21288656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose and Fractionation in Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: Lessons Learned and Where Do We Go Next?
    Guckenberger M
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):765-8. PubMed ID: 26530744
    [No Abstract]   [Full Text] [Related]  

  • 29. Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree.
    Haseltine JM; Rimner A; Gelblum DY; Modh A; Rosenzweig KE; Jackson A; Yorke ED; Wu AJ
    Pract Radiat Oncol; 2016; 6(2):e27-33. PubMed ID: 26577006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving outcomes for high-risk patients with early-stage non-small-cell lung cancer: insights from population-based data and the role of stereotactic ablative radiotherapy.
    Palma DA; Senan S
    Clin Lung Cancer; 2013 Jan; 14(1):1-5. PubMed ID: 22846581
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
    Mattonen SA; Palma DA; Johnson C; Louie AV; Landis M; Rodrigues G; Chan I; Etemad-Rezai R; Yeung TP; Senan S; Ward AD
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1121-8. PubMed ID: 26907916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Stage I Lung Cancer with Stereotactic Ablative Radiation Therapy.
    Dan T; Williams NL
    Surg Oncol Clin N Am; 2017 Jul; 26(3):393-403. PubMed ID: 28576179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Stereotactic body radiation therapy for early non-small cell lung cancer].
    Zhang HQ; Li MH; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):561-3. PubMed ID: 22325212
    [No Abstract]   [Full Text] [Related]  

  • 34. [Stereotactic ablative irradiation for lung cancer].
    Antoni D; Srour I; Noël G; Mornex F
    Cancer Radiother; 2014; 18(4):297-307. PubMed ID: 24907006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should stereotactic ablative body radiotherapy be the standard of care in oligometastatic cancer?
    Correa RJM; Palma DA
    Lancet Oncol; 2021 Jan; 22(1):6-8. PubMed ID: 33387496
    [No Abstract]   [Full Text] [Related]  

  • 36. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
    Shultz DB; Filippi AR; Thariat J; Mornex F; Loo BW; Ricardi U
    J Thorac Oncol; 2014 Oct; 9(10):1426-33. PubMed ID: 25170641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest.
    Shultz DB; Trakul N; Maxim PG; Diehn M; Loo BW
    Pract Radiat Oncol; 2014; 4(4):272-8. PubMed ID: 25012837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
    Brown WT; Wu X; Fayad F; Fowler JF; Amendola BE; García S; Han H; de la Zerda A; Bossart E; Huang Z; Schwade JG
    Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study.
    Ferrero C; Badellino S; Filippi AR; Focaraccio L; Giaj Levra M; Levis M; Moretto F; Torchio R; Ricardi U; Novello S
    Lung Cancer; 2015 Sep; 89(3):350-6. PubMed ID: 26164208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer.
    Timmerman R; Galvin J; Michalski J; Straube W; Ibbott G; Martin E; Abdulrahman R; Swann S; Fowler J; Choy H
    Acta Oncol; 2006; 45(7):779-86. PubMed ID: 16982540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.